Viking Therapeutics Inc. (VKTX)

AI Score

Unlock

24.14

-1.54 (-6.00%)

At close: Apr 03, 2025, 3:59 PM

23.30

-3.46%

Pre-market: Apr 04, 2025, 09:00 AM EDT

Viking Therapeutics Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Cash & Equivalents	26.68M	55.52M	36.63M	26.37M	29.12M	8.38M	24.78M	8.99M	3.08M	768.55K	755.86K	179.62K	n/a
Short-Term Investments	875.94M	306.56M	118.85M	175.73M	219.27M	267.26M	276.74M	11.59M	10.08M	13.34M	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	102K	139K	71K	109K	77K	157K	179K	269.61K	560.88K	237.46K	2.27M	775.00	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.13M	2.52M	3.41M	7.81M	n/a	n/a	n/a	388.97K	824.27K	1.1M	n/a	n/a	n/a
Total Current Assets	907.22M	367.23M	167.04M	210.53M	256.1M	283.5M	302.13M	21.85M	13.97M	15.2M	773.68K	179.62K	n/a
Property-Plant & Equipment	1M	1.13M	1.42M	25K	321K	598K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.1M	1.26M	1.49M	134K	398K	755K	179K	269.61K	560.88K	237.46K	2.27M	775.00	n/a
Total Assets	908.32M	368.49M	168.53M	210.66M	256.5M	284.26M	302.31M	22.12M	14.54M	15.44M	3.04M	180.39K	n/a
Account Payables	9.81M	7.51M	8.53M	1.44M	3.99M	2.43M	959K	1.53M	1.2M	592.41K	1.83M	74.09K	54.03K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.28M	1.27M	n/a	20.32M	n/a	n/a
Short-Term Debt	489K	n/a	304K	29K	330K	302K	n/a	3.45M	3.27M	n/a	304.27K	46.89K	n/a
Other Current Liabilities	17.11M	n/a	-304K	-29K	-330K	-302K	n/a	1.4M	731.05K	n/a	58.74K	n/a	n/a
Total Current Liabilities	27.41M	19.14M	21.95M	8.78M	12.13M	6.78M	4.55M	8.66M	6.48M	1.98M	22.52M	127.49K	54.38K
Long-Term Debt	630K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.15M	1.26M	231.85K	42.75K
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	12K	n/a	16.31K	2.59M	1.39M	71.66K	8.29K
Total Long-Term Liabilities	630K	936K	1.26M	n/a	29K	360K	12K	4.98M	16.31K	4.74M	2.65M	303.51K	51.04K
Total Liabilities	28.04M	20.07M	23.21M	8.78M	12.16M	7.14M	4.56M	8.66M	6.49M	6.71M	25.17M	431K	105.42K
Total Debt	1.12M	1.26M	1.56M	29K	359K	662K	n/a	3.45M	3.27M	2.15M	1.57M	278.75K	42.75K
Common Stock	1K	1K	1K	1K	1K	1K	1K	358.00	208.00	97.00	60.00	52.00	50.00
Retained Earnings	-487.91M	-377.94M	-292.05M	-223.18M	-168.19M	-128.7M	-102.92M	-80.85M	-60.28M	-45.55M	-22.14M	-257.27K	-111.03K
Comprehensive Income	-788K	-389K	-1.1M	-549K	-54K	12K	-423K	-19.77K	-6.89K	-7.37K	n/a	-4.5K	n/a
Shareholders Equity	880.28M	348.42M	145.32M	201.88M	244.34M	277.12M	297.75M	13.46M	8.04M	8.72M	-22.13M	-250.6K	-105.42K
Total Investments	875.94M	306.56M	118.85M	175.73M	219.27M	267.26M	276.74M	11.59M	10.08M	13.34M	n/a	n/a	n/a